Literature DB >> 1256944

Central hypoventilation during quiet sleep in two infants.

D C Shannon, D W Marsland, J B Gould, B Callahan, I D Todres, J Dennis.   

Abstract

Expired ventilation (VE), tidal volume (VT), frequency (f), and alveolar PCO2 (PACO2) were examined in six normal infants at 41 to 52 weeks post-conceptional age and in two infants who were apneic at birth. Their response to breathing 5% carbon dioxide in air and to 100% oxygen in quiet sleep were compared to those in rapid eye movement (REM) sleep. VE in normal infants was 259 ml/kg/min in REM and 200.2 ml/kg/min in quiet sleep with the difference being due to decreased carbon dioxide production and to decreased dead space. VE increased 34.4 ml/kg/min/mm Hg of PCO2 elevation with 5% carbon dioxide breathing during REM and was not significantly different during quiet sleep. During oxygen breathing VE fell by 32.7% at 30 seconds before increasing again. In the affected infants, VE and PACO2 during REM at 1 and 4 months were normal. At 1 month, during quiet sleep, each infant became apneic and PACO2 rose 9 and 8 mm Hg/min respectively. At this time mechanical ventilation was begun. At 4 months, during quiet sleep, VE was 0.064 and 0.063 ml/kg/min at PACO2 of 66 mm Hg in each infant. The change was due entirely to a decrease in VT to 2.3 and 2.5 ml/kg. At this time 5% carbon dioxide breathing given during normal ventilation in REM produced an abrupt fall in VT to 2.0 and 2.2 ml/kg with no change in frequency. Oxygen breathing during REM at one month had no effect but at 4 months produced apnea requiring mechanical ventilation after one minute. The findings suggest that the ventilatory response to carbon dioxide is (1) important in initiation of extrauterine ventilation and (2) in sustaining ventilation particularly in quiet sleep. It is not necessary in sustaining ventilation awake or in REM sleep and it represents a balance between the stimulatory and depressant effects of carbon dioxide on the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1256944

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  8 in total

1.  Sheffield, 28 and 29 march 1980.

Authors: 
Journal:  Arch Dis Child       Date:  1980-10       Impact factor: 3.791

2.  Congenital central alveolar hypoventilation (Ondine's curse): a case report and review of the literature.

Authors:  F Yasuma; H Nomura; I Sotobata; H Ishihara; H Saito; K Yasuura; H Okamoto; S Hirose; T Abe; A Seki
Journal:  Eur J Pediatr       Date:  1987-01       Impact factor: 3.183

3.  REM sleep prevents sudden infant death syndrome.

Authors:  K Watanabe; K Inokuma; T Negoro
Journal:  Eur J Pediatr       Date:  1983-09       Impact factor: 3.183

Review 4.  Congenital central hypoventilation syndrome and the PHOX2B gene: a model of respiratory and autonomic dysregulation.

Authors:  Pallavi P Patwari; Michael S Carroll; Casey M Rand; Rajesh Kumar; Ronald Harper; Debra E Weese-Mayer
Journal:  Respir Physiol Neurobiol       Date:  2010-06-30       Impact factor: 1.931

5.  Congenital central hypoventilation syndrome (Ondine's curse syndrome) in two siblings: delayed diagnosis and successful noninvasive treatment.

Authors:  R Kerbl; H Litscher; H M Grubbauer; F Reiterer; G Zobel; M Trop; B Urlesberger; E Eber; R Kurz
Journal:  Eur J Pediatr       Date:  1996-11       Impact factor: 3.183

Review 6.  Congenital central hypoventilation syndrome: a bedside-to-bench success story for advancing early diagnosis and treatment and improved survival and quality of life.

Authors:  Debra E Weese-Mayer; Casey M Rand; Amy Zhou; Michael S Carroll; Carl E Hunt
Journal:  Pediatr Res       Date:  2016-09-27       Impact factor: 3.756

7.  Ventilatory responses to exercise in humans lacking ventilatory chemosensitivity.

Authors:  S A Shea; L P Andres; D C Shannon; R B Banzett
Journal:  J Physiol       Date:  1993-08       Impact factor: 5.182

8.  Infant sleep apnea profile: preterm vs. term infants.

Authors:  M Albani; K H Bentele; C Budde; F J Schulte
Journal:  Eur J Pediatr       Date:  1985-03       Impact factor: 3.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.